IL126175A - Pharmaceutical compositions containing endothelin antagonists and novel endothelin antagonists - Google Patents

Pharmaceutical compositions containing endothelin antagonists and novel endothelin antagonists

Info

Publication number
IL126175A
IL126175A IL12617597A IL12617597A IL126175A IL 126175 A IL126175 A IL 126175A IL 12617597 A IL12617597 A IL 12617597A IL 12617597 A IL12617597 A IL 12617597A IL 126175 A IL126175 A IL 126175A
Authority
IL
Israel
Prior art keywords
endothelin antagonists
pharmaceutical compositions
compositions containing
novel
antagonists
Prior art date
Application number
IL12617597A
Other languages
English (en)
Other versions
IL126175A0 (en
Original Assignee
Banyu Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Pharma Co Ltd filed Critical Banyu Pharma Co Ltd
Publication of IL126175A0 publication Critical patent/IL126175A0/xx
Publication of IL126175A publication Critical patent/IL126175A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Materials For Photolithography (AREA)
  • Photosensitive Polymer And Photoresist Processing (AREA)
IL12617597A 1996-04-04 1997-03-19 Pharmaceutical compositions containing endothelin antagonists and novel endothelin antagonists IL126175A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1488296P 1996-04-04 1996-04-04
PCT/US1997/003737 WO1997037665A1 (en) 1996-04-04 1997-03-19 Method of treating heart failure with endothelin antagonists

Publications (2)

Publication Number Publication Date
IL126175A0 IL126175A0 (en) 1999-05-09
IL126175A true IL126175A (en) 2003-05-29

Family

ID=21768326

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12617597A IL126175A (en) 1996-04-04 1997-03-19 Pharmaceutical compositions containing endothelin antagonists and novel endothelin antagonists

Country Status (25)

Country Link
US (3) US5834483A (xx)
EP (1) EP0906108B1 (xx)
JP (2) JP3345891B2 (xx)
KR (1) KR20000005178A (xx)
CN (1) CN1215335A (xx)
AT (1) ATE297739T1 (xx)
AU (1) AU723351B2 (xx)
BG (1) BG102716A (xx)
BR (1) BR9708525A (xx)
CA (1) CA2249330C (xx)
CZ (1) CZ296098A3 (xx)
DE (1) DE69733557T2 (xx)
EA (1) EA003587B1 (xx)
EE (1) EE9800315A (xx)
ES (1) ES2241047T3 (xx)
HU (1) HUP9903893A3 (xx)
IL (1) IL126175A (xx)
IS (1) IS4847A (xx)
NO (1) NO984564L (xx)
NZ (1) NZ331789A (xx)
PL (1) PL329077A1 (xx)
SK (1) SK130098A3 (xx)
TR (1) TR199801988T2 (xx)
UA (1) UA50761C2 (xx)
WO (1) WO1997037665A1 (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69733557T2 (de) * 1996-04-04 2005-11-03 Banyu Pharmaceutical Co., Ltd. Endothelin-antagonisten zur behandlung von herzversagen
WO1998006700A1 (en) * 1996-08-09 1998-02-19 Merck & Co., Inc. Stereoselective deoxygenation reaction
EP1049691B1 (en) 1998-01-21 2004-02-18 Banyu Pharmaceutical Co., Ltd. Substituted 5-(2,2-difluoro-1,3-benzodioxol-5-yl) cyclopentenopyridine derivative
US8168616B1 (en) 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
WO2004060885A1 (ja) * 2002-12-27 2004-07-22 Kaneka Corporation 光学活性２−チオメチル−３−フェニルプロピオン酸誘導体およびその合成中間体の製造法
KR20120008093A (ko) 2003-11-17 2012-01-25 노파르티스 아게 디펩티딜 펩티다제 ⅳ 억제제의 용도
GB0327839D0 (en) 2003-12-01 2003-12-31 Novartis Ag Organic compounds
CA2558020A1 (en) 2004-03-17 2005-09-29 Novartis Ag Use of renin inhibitors in therapy
WO2006137222A1 (ja) 2005-06-24 2006-12-28 Tokyo Medical And Dental University 薬剤溶出速度制御方法、及び薬剤溶出性ステント被膜用組成物
WO2011116115A1 (en) 2010-03-16 2011-09-22 Novartis Ag Aliskiren composition comprising a medium chain fatty acid, their process of manufacturing

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4971959A (en) * 1987-04-14 1990-11-20 Warner-Lambert Company Trisubstituted phenyl analogs having activity for congestive heart failure
GB9007762D0 (en) * 1990-04-05 1990-06-06 Beecham Group Plc Novel compounds
US5565485A (en) * 1993-03-19 1996-10-15 Merck & Co., Inc. Biphenyl compounds useful or endothelin antagonists
US5571813A (en) * 1993-06-10 1996-11-05 Beiersdorf-Lilly Gmbh Fused pyrimidine compounds and their use as pharmaceuticals
US5389620A (en) * 1993-08-18 1995-02-14 Banyu Pharmaceutical Co., Ltd. Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives
CN1049219C (zh) * 1993-08-18 2000-02-09 万有制药株式会社 具有内皮素拮抗活性的芳香杂环并环戊烯衍生物
US5658943A (en) * 1995-01-05 1997-08-19 Warner-Lambert Company Phenylalanine derivatives as endothelin antagonists
DE69733557T2 (de) * 1996-04-04 2005-11-03 Banyu Pharmaceutical Co., Ltd. Endothelin-antagonisten zur behandlung von herzversagen

Also Published As

Publication number Publication date
PL329077A1 (en) 1999-03-15
BG102716A (en) 1999-09-30
US6380195B1 (en) 2002-04-30
EP0906108A1 (en) 1999-04-07
CN1215335A (zh) 1999-04-28
HUP9903893A3 (en) 2001-05-28
CA2249330C (en) 2005-08-09
US5834483A (en) 1998-11-10
IS4847A (is) 1998-09-15
NZ331789A (en) 2000-05-26
AU723351B2 (en) 2000-08-24
EP0906108A4 (en) 2000-12-06
JP3345891B2 (ja) 2002-11-18
KR20000005178A (ko) 2000-01-25
EA199800889A1 (ru) 1999-04-29
ES2241047T3 (es) 2005-10-16
DE69733557D1 (de) 2005-07-21
CZ296098A3 (cs) 1999-06-16
IL126175A0 (en) 1999-05-09
EE9800315A (et) 1999-06-15
NO984564L (no) 1998-12-04
NO984564D0 (no) 1998-09-30
BR9708525A (pt) 1999-08-03
US6087360A (en) 2000-07-11
TR199801988T2 (xx) 2000-08-21
AU2202597A (en) 1997-10-29
HUP9903893A2 (hu) 2001-04-28
SK130098A3 (en) 1999-05-07
JP2000510824A (ja) 2000-08-22
JP2002220337A (ja) 2002-08-09
DE69733557T2 (de) 2005-11-03
CA2249330A1 (en) 1997-10-16
WO1997037665A1 (en) 1997-10-16
EP0906108B1 (en) 2005-06-15
UA50761C2 (uk) 2002-11-15
EA003587B1 (ru) 2003-06-26
ATE297739T1 (de) 2005-07-15

Similar Documents

Publication Publication Date Title
CA2289717A1 (en) Novel therapy for constipation
IL147852A0 (en) Chemokine receptor antagonists and pharmaceutical compositions containing the same
EP1428821A8 (en) Piperidin-4-yl amines with analgesic effect
UA49869C2 (uk) Нафтил-заміщені похідні бензимідазолу, фармацевтична композиція, спосіб лікування (варіанти) та спосіб інгібування людського фактора
MY119403A (en) Novel compounds with analgesic effect.
ES2055911T3 (es) Compuesto farmaceutico adelgazante.
DE122011100032I1 (de) Verwendung von n-substituierten pyridonen als tumornekrose-faktor alpha hemmer.
IL137266A0 (en) Heterocyclic chemokine receptor antagonists and pharmaceutical compositions containing the same
WO2001030802A3 (en) Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies
CA2378613A1 (en) Selective iglur5 receptor antagonists for the treatment of migraine
MY109309A (en) Improvements in or relating to somatostatins
EP0911331A3 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
HU9700654D0 (en) Antitussive compositions
IL126175A (en) Pharmaceutical compositions containing endothelin antagonists and novel endothelin antagonists
IL136733A0 (en) Pharmaceutical composition containing sibutramine and orlistat
MY126321A (en) Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer.
IL127851A0 (en) Inhibition of TNF activity
EP1050303A3 (en) Methods and compositions for treating age-related behavioral disorders in companion animals
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
HUP9801894A2 (hu) Dofetilid alkalmazása kongesztív szívpanaszok kezelésére szolgáló gyógyszerkészítmények előállítására
MX9702899A (es) Compuestos y composiciones para suministrar agentes activos.

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees